http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0288538-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9cb217f83556ce2a418344c2d485415
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J27-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
filingDate 1988-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b82cb6767e52d8bbd4619711197affe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b71f8f477355e14c525815693ef878c
publicationDate 1990-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0288538-A
titleOfInvention 2-hydroxy-2-(4-substituted)propione
abstract PURPOSE: To industrially advantageously obtain the title compound useful as an intermediate for antiphlogistic, analgesic and antipyretic agents in one stage and easy reaction operation by reacting substituted benzenes with pyruvic acid in the presence of Lewis acid in a solvent and then hydrolyzing the resultant product. n CONSTITUTION: For example, substituted benzenes expressed by formula I or formula II (X and Y are 1-5C straight-chain or branched alkyl and further X is halogen) are reacted with pyruvic acid of 0.3-4 times by mol, preferably 0.5-2.5 times by mol based on the above-mentioned compound in the presence of a Lewis acid, preferably inorganic acid, especially inorganic aluminum chloride of 0.1-7 times by mol, preferably 0. 5-3 times by mol based on the above- mentioned compound in a solvent (preferably methylene chloride), normally at - 60 to +60°C, preferably at -40to +30°C and then hydrolyzed to industrially advantageously provide the title compound useful as a precursor for 2-(4- substituted phenyl)propionic acid (the above-mentioned medicine). n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5143364-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5181710-A
priorityDate 1988-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S532449-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0098012-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S53144553-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410760501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546766

Total number of triples: 31.